ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,334,569 | -23.7% | 1,228,245 | -13.6% | 0.23% | -30.5% |
| Q2 2023 | $43,683,692 | +89.9% | 1,421,070 | +122.6% | 0.32% | +61.7% |
| Q1 2023 | $23,001,336 | +13.4% | 638,394 | +24.4% | 0.20% | -4.3% |
| Q4 2022 | $20,274,827 | +36.0% | 513,027 | +44.6% | 0.21% | +22.8% |
| Q2 2022 | $14,913,000 | +421.6% | 354,729 | +383.3% | 0.17% | +434.4% |
| Q1 2022 | $2,859,000 | -36.7% | 73,394 | -41.3% | 0.03% | -42.9% |
| Q3 2021 | $4,518,000 | -68.7% | 125,000 | -64.4% | 0.06% | -66.5% |
| Q2 2021 | $14,412,000 | +1.2% | 351,597 | +7.7% | 0.17% | -9.2% |
| Q1 2021 | $14,246,000 | -62.7% | 326,597 | -57.2% | 0.18% | -65.9% |
| Q4 2020 | $38,229,000 | +80.4% | 763,817 | +51.6% | 0.54% | +67.7% |
| Q3 2020 | $21,192,000 | +0.3% | 503,735 | +15.7% | 0.32% | +0.6% |
| Q2 2020 | $21,129,000 | – | 435,195 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |